BioPharmSignal logoBioPharmSignal

Biotech News

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

IRIDEX (IRIX)IRIDEXEarnings

MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release

Open original release

Related news

IRIXIRIDEX2026-05-19 20:05 EST

Iridex Reports First Quarter 2026 Financial Results

ICCMIceCure Medical2026-05-06 12:30 EST

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

TARSTarsus Pharmaceuticals2026-04-29 20:30 EST

Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026

OCULOcular Therapeutix2026-04-28 11:00 EST

Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026

CVRXCVRx2026-04-27 20:30 EST

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

OMOutset Medical2026-04-27 20:05 EST

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

TMCITreace Medical Concepts2026-04-24 11:05 EST

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

RXSTRxSight2026-04-22 20:10 EST

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

SGHTSight Sciences2026-04-21 20:05 EST

Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026

ADPTAdaptive Biotechnologies2026-04-15 20:05 EST

Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026

View all latest news

IRIDEX

IRIDEX is a medical device company focused on ophthalmic laser systems and eye-care procedures. Its business is built around retina and glaucoma treatment platforms.

Recent company news

IRIXIRIDEX2026-05-19 20:05 EST

Iridex Reports First Quarter 2026 Financial Results

IRIXIRIDEX2026-05-05 20:05 EST

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

IRIXIRIDEX2026-04-07 20:05 EST

Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology

IRIXIRIDEX2026-03-26 20:05 EST

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

IRIXIRIDEX2026-03-12 20:05 EST

Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026

Stock data

Close
0.89 USD
Market cap
20.37M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States